TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/09/2025
Back to search
Official data from USPTO
SUTRO BIOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
SUTRO BIOPHARMA
ST13
US500000085750000Class
5, 40, 42
Filing
85750000
Registration
4576532
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
12/11/2025
Classification
Registered
Trademark type
Word
Nice classes
5, 40, 42
Filing date
10/10/2012
Registration date
07/29/2014
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/26/2024
Last transaction
12/11/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/22/2013
First use in commerce
10/22/2013
Drawing code
4
Owner type
03
Owner location
South San Francisco, CA
Examiner
LAW,CHRISTOPHER M
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Sutro Biopharma, Inc.
Representatives
Karen Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsproteins and derivatives thereof for prophylacticdiagnostictherapeutic use in the nature of treating cancercardiovascularhematopoieticcentral nervous systemautoimmuneinfectiousskin and skin structurebonegeneticendocrine or metabolic type diseases and ailments in humans and animals
Class 40
Manufacture of pharmaceutical preparations for others
Class 42
Research and development of pharmaceutical preparations for others
Publications
History of USPTO decisions and trademark events.
50 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/09/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/09/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/26/2024
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/26/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/26/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/26/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
07/30/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/29/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/06/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/06/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/06/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/25/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/25/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/25/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/25/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/25/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/24/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/24/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/23/2020
E815
TEAS SECTION 8 & 15 RECEIVED
07/28/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/29/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
07/29/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/27/2014
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
06/26/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/24/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/02/2014
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/20/2014
IUAF
USE AMENDMENT FILED
04/28/2014
EISU
TEAS STATEMENT OF USE RECEIVED
04/28/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/05/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/10/2013
PUBO
PUBLISHED FOR OPPOSITION
09/10/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/21/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/02/2013
ALIE
ASSIGNED TO LIE
08/02/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/18/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/18/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/18/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/18/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/08/2013
GNRT
NON-FINAL ACTION E-MAILED
02/08/2013
CNRT
NON-FINAL ACTION WRITTEN
02/08/2013
DOCK
ASSIGNED TO EXAMINER
02/07/2013
MPMK
NOTICE OF PSEUDO MARK MAILED
10/17/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/16/2012
NWAP
NEW APPLICATION ENTERED
10/13/2012
Continuous trademark protection
Get notified about every new filing that threatens SUTRO BIOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.